MDR classification: the 22 rules of Annex VIII explained
How Annex VIII of the MDR places a medical device in class I, IIa, IIb or III: the four families of rules, duration, invasiveness, body part and active status, Rule 11 and software, the strictest rule, common pitfalls and the conformity assessment procedure each class leads to, article by article.
By Iohannès Bry · Updated on November 15, 2026 · 14 min read
In short. The MDR divides medical devices into classes I, IIa, IIb and III, taking into account their intended purpose and their inherent risks, according to the rules of its Annex VIII (Article 51(1)). Those 22 rules form four families — non-invasive devices (Rules 1 to 4), invasive devices (5 to 8), active devices (9 to 13) and special rules (14 to 22) — and where several of them apply to the same device, the strictest rule applies and the device takes the higher class (Annex VIII, Section 3.5). Software is an active device (Article 2(4)): Rule 11 classifies it, unless it drives a device or influences its use, in which case it falls within the class of that device (Section 3.3); the class chosen, justified in the manufacturer's technical documentation (Annex II, Section 1.1(f)), sets the conformity assessment procedure (Article 52).
Who classifies, and on what basis
Article 51(1) sets the principle:
Devices shall be divided into classes I, IIa, IIb and III, taking into account the intended purpose of the devices and their inherent risks. Classification shall be carried out in accordance with Annex VIII.
| Question | What the text says | Basis |
|---|---|---|
| What the class rests on | Application of the rules is governed by the intended purpose of the devices | Annex VIII, Section 3.1 |
| Where the class is recorded | The manufacturer's technical documentation states the risk class and the justification for the classification rule(s) applied | Annex II, Section 1.1(f) |
| Who settles a disagreement | A dispute between the manufacturer and its notified body arising from the application of Annex VIII goes to the competent authority of the manufacturer's Member State | Article 51(2) |
| What the class triggers | The conformity assessment procedure, which differs by class | Article 52(3), (4), (6) and (7) |
Classifying the device and justifying the class is therefore the manufacturer's job. The classification tool asks the questions of Annex VIII and gives an indicative class, with the rule or rules applied and their official text: it helps prepare that justification, it does not replace it.
The four families of rules
Chapter III of Annex VIII groups the 22 rules into four sections. A rule of one family applies to any device that meets its conditions; the special rules come on top of the others, and Section 3.5 decides between them.
| Family (Annex VIII) | Rules |
|---|---|
| Non-invasive devices (Section 4) | 1, 2, 3, 4 |
| Invasive devices (Section 5) | 5, 6, 7, 8 |
| Active devices (Section 6) | 9, 10, 11, 12, 13 |
| Special rules (Section 7) | 14, 15, 16, 17, 18, 19, 20, 21, 22 |
Each rule has its own page, with its full official text, its definitions and the examples from the MDCG 2021-24 guidance. The table below gives only its subject and the classes it can assign.
| Rule | Subject | Classes assigned by the rule |
|---|---|---|
| Rule 1 | Non-invasive devices: the default rule | I |
| Rule 2 | Channelling or storing blood, liquids, tissues or gases | I, IIa, IIb |
| Rule 3 | Modifying the composition of blood, tissues or liquids | IIa, IIb, III |
| Rule 4 | Contact with injured skin or mucous membrane | I, IIa, IIb |
| Rule 5 | Devices invasive with respect to body orifices | I, IIa, IIb |
| Rule 6 | Surgically invasive devices for transient use | I, IIa, IIb, III |
| Rule 7 | Surgically invasive devices for short-term use | IIa, IIb, III |
| Rule 8 | Implantable and long-term surgically invasive devices | IIa, IIb, III |
| Rule 9 | Active therapeutic devices | IIa, IIb, III |
| Rule 10 | Active devices for diagnosis and monitoring | I, IIa, IIb |
| Rule 11 | Software | I, IIa, IIb, III |
| Rule 12 | Administering or removing medicinal products, body liquids or substances | IIa, IIb |
| Rule 13 | All other active devices | I |
| Rule 14 | Devices incorporating a medicinal substance | III |
| Rule 15 | Contraception and prevention of sexually transmitted diseases | IIb, III |
| Rule 16 | Disinfection, sterilisation and contact lens care | IIa, IIb |
| Rule 17 | Recording X-ray diagnostic images | IIa |
| Rule 18 | Tissues or cells of human or animal origin | III |
| Rule 19 | Nanomaterials | IIa, IIb, III |
| Rule 20 | Administering medicinal products by inhalation | IIa, IIb |
| Rule 21 | Devices composed of substances | IIa, IIb, III |
| Rule 22 | Active therapeutic devices with an integrated diagnostic function | III |
Rules 1 and 13 only apply by default: all non-invasive devices are in class I unless one of the following rules applies (Rule 1), and Rule 13 places all other active devices in class I.
The cross-cutting criteria
Four questions come back in almost every rule. The definitions that answer them are in Chapter I of Annex VIII and in Article 2.
Duration of use
| Duration | Meaning | Basis |
|---|---|---|
| Transient | Normally intended for continuous use for less than 60 minutes | Annex VIII, Section 1.1 |
| Short term | Normally intended for continuous use for between 60 minutes and 30 days | Annex VIII, Section 1.2 |
| Long term | Normally intended for continuous use for more than 30 days | Annex VIII, Section 1.3 |
Continuous use means the entire duration of use of the same device, without regard to a temporary interruption of use during a procedure or temporary removal for cleaning or disinfection; it also covers the accumulated use of a device that the manufacturer intends to be replaced immediately with another of the same type (Annex VIII, Section 3.6).
Invasiveness
- Invasive: the device penetrates inside the body, in whole or in part, through a body orifice or through the surface of the body (Article 2(6)).
- Body orifice: any natural opening in the body, the external surface of the eyeball and any permanent artificial opening, such as a stoma (Annex VIII, Section 2.1). This is the field of Rule 5.
- Surgically invasive: the device penetrates through the surface of the body, including mucous membranes of body orifices, with the aid or in the context of a surgical operation, or produces penetration other than through a body orifice (Annex VIII, Section 2.2). Depending on duration, Rules 6, 7 and 8 apply.
- Implantable: totally introduced into the human body, or replacing an epithelial surface or the surface of the eye, by clinical intervention, and intended to remain in place; a device partially introduced that remains in place for at least 30 days is also implantable (Article 2(5)). It falls under Rule 8.
Part of the body
Several rules vary the class according to the part of the body: direct contact with the heart, the central circulatory system or the central nervous system (class III under Rules 6, 7 and 8), the oral cavity as far as the pharynx, the ear canal up to the ear drum or the nasal cavity (a lower class under Rule 5). The central circulatory system means the blood vessels listed in Section 2.6 of Annex VIII; the central nervous system means the brain, meninges and spinal cord (Section 2.7). A device that is not intended to be used solely or principally in a specific part of the body is classified on the basis of the most critical specified use (Section 3.4).
Active or not
An active device depends on a source of energy other than that generated by the human body or by gravity, and acts by changing the density of or converting that energy; a device that transmits energy, substances or other elements between an active device and the patient without any significant change is not active (Article 2(4)). Rules 9 to 13 classify active devices: therapeutic (Rule 9), for diagnosis and monitoring (Rule 10), software (Rule 11), administering or removing substances (Rule 12), and all others (Rule 13).
Rule 11 and software
The same provision, Article 2(4), counts software among active devices:
Software shall also be deemed to be an active device
Before Rule 11 comes into play, Section 3.3 of Annex VIII settles a preliminary question:
Software, which drives a device or influences the use of a device, shall fall within the same class as the device.
If the software is independent of any other device, it shall be classified in its own right.
Software that drives a device or influences its use therefore follows the class of that device. Independent software is classified in its own right; as an active device, it belongs to the family of Rules 9 to 13, where Rule 11 is devoted to it:
Software intended to provide information which is used to take decisions with diagnosis or therapeutic purposes is classified as class IIa, except if such decisions have an impact that may cause:
- death or an irreversible deterioration of a person's state of health, in which case it is in class III; or
- a serious deterioration of a person's state of health or a surgical intervention, in which case it is classified as class IIb.
Software intended to monitor physiological processes is classified as class IIa, except if it is intended for monitoring of vital physiological parameters, where the nature of variations of those parameters is such that it could result in immediate danger to the patient, in which case it is classified as class IIb.
All other software is classified as class I.
| What the software does | Class | Rule 11 |
|---|---|---|
| Provides information used for a diagnostic or therapeutic decision | IIa | First paragraph |
| Same, where the decision may cause a serious deterioration or a surgical intervention | IIb | Second indent |
| Same, where the decision may cause death or an irreversible deterioration | III | First indent |
| Monitors physiological processes | IIa | Second paragraph |
| Monitors vital parameters whose variations could result in immediate danger | IIb | Second paragraph |
| All other software | I | Third paragraph |
An active therapeutic device with an integrated or incorporated diagnostic function which significantly determines the patient management by the device, such as a closed loop system, is in class III (Rule 22); software that drives it follows its class (Section 3.3). The MDCG 2021-24 Rev.1 guidance gives examples of software under Rule 11; the rule's page quotes them.
Several rules: the higher class
A device often falls under several rules, or under several indents of the same rule. Section 3.5 of Annex VIII decides:
If several rules, or if, within the same rule, several sub-rules, apply to the same device based on the device's intended purpose, the strictest rule and sub-rule resulting in the higher classification shall apply.
Finding one rule that fits is therefore not enough: all 22 have to be checked, in particular the special Rules 14 to 22, which come on top of the family rule. An implantable device under Rule 8 that incorporates, as an integral part, a substance which, if used separately, can be considered to be a medicinal product, with an action ancillary to that of the device, also falls under Rule 14, which assigns class III: that is the rule that applies. Two other principles of Annex VIII prevent double counting:
- a device used in combination with another is classified separately, and an accessory is classified in its own right, separately from the device with which it is used (Section 3.2);
- a device not intended for a specific part of the body is classified on the basis of its most critical specified use (Section 3.4).
Common pitfalls
- Counting the duration of a single device when it is replaced in series. A temporary interruption does not reset the count, and a device replaced immediately with another of the same type accumulates the durations (Annex VIII, Section 3.6).
- Forgetting the partially implanted device. Partially introduced by clinical intervention and left in place for at least 30 days, the device is implantable (Article 2(5)) and falls under Rule 8.
- Assuming Rule 4 covers only non-invasive devices. It also applies to invasive devices that come into contact with injured mucous membrane (Rule 4, last paragraph).
- Putting every reusable surgical instrument in class I. The definition requires it to be used without a connection to an active device (Annex VIII, Section 2.3); and Rule 6 covers transient use only.
- Stretching the joint replacement exception. Total or partial joint replacements are in class III; only ancillary components such as screws, wedges, plates and instruments are excluded (Rule 8).
- Applying Rule 16 to plain cleaning. It does not apply to devices intended to clean devices other than contact lenses by means of physical action only (Rule 16, last paragraph).
- Confusing human and animal tissues. Rule 18 takes out of class III only devices manufactured utilising tissues or cells of animal origin, or their derivatives, which are non-viable or rendered non-viable and are intended to come into contact with intact skin only.
- Treating a simple connector as active. A device that transmits energy or substances between an active device and the patient without any significant change is not an active device (Article 2(4)).
- Assuming class I never needs a notified body. Class I devices placed on the market in sterile condition, with a measuring function or that are reusable surgical instruments go through a notified body, for those aspects only (Article 52(7)).
From class to conformity assessment
The class is not just a label: Article 52 makes the conformity assessment procedure depend on it. Other than for custom-made or investigational devices:
| Class | Procedure | Basis |
|---|---|---|
| I | EU declaration of conformity (Article 19) issued after drawing up the technical documentation of Annexes II and III. If the device is sterile, has a measuring function or is a reusable surgical instrument: Chapters I and III of Annex IX, or Part A of Annex XI, with the notified body involved in those aspects only | Article 52(7) |
| IIa | Chapters I and III of Annex IX, with assessment of the technical documentation of at least one representative device for each category; or the technical documentation of Annexes II and III with Section 10 or 18 of Annex XI | Article 52(6) |
| IIb | Chapters I and III of Annex IX, with assessment of the technical documentation of at least one representative device per generic device group, and of every device if it is implantable, except those the paragraph lists; or Annex X with Annex XI | Article 52(4) |
| III | Annex IX; or Annex X with Annex XI | Article 52(3) |
For class I, the text is explicit:
Manufacturers of class I devices, other than custom-made or investigational devices, shall declare the conformity of their products by issuing the EU declaration of conformity referred to in Article 19 after drawing up the technical documentation set out in Annexes II and III.
Each class has its own Normiq roadmap, step by step: class I, class IIa, class IIb and class III. The classification tool links to the roadmap of the class it indicates.
In Switzerland
The MedDO does not copy the rules: it refers to Annex VIII of the MDR (MedDO Article 15, in Fedlex's unofficial English translation):
Devices shall be divided into classes I, IIa, IIb and III, taking into account the intended purpose of the devices and their inherent risks. This classification must comply with the provisions of Annex VIII to EU-MDR, taking account of the implementing acts of the European Commission listed in Annex 5a.
For the Swiss market, the rules to apply are therefore those of Annex VIII of the MDR, taking account of the implementing acts listed in Annex 5a of the MedDO.
Sources
- Regulation (EU) 2017/745 (MDR), consolidated version of 19 July 2026: Articles 2, 51 and 52, Annexes II and VIII
- MDCG 2021-24 Rev.1, Guidance on classification of medical devices (April 2026)
- Swiss Medical Devices Ordinance (MedDO, SR 812.213), Article 15, version of 1 July 2026 (unofficial English translation)
Read next
From the text to your device's roadmap
Normiq places every requirement in your device's roadmap, with the steps that lead to it. Free 7-day trial.
Start the free trial